Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
May 24, 2019
IDEAYA Announces Pricing of Initial Public Offering
May 17, 2019
CinCor Pharma In-Licenses Aldosterone Synthase Inhibitor, CIN-107, and Closes $50 Million Series A Financing
May 17, 2019
Homology Medicines Announces FDA Fast Track Designation for HMI-102 Gene Therapy Development Candidate for Adults with PKU
May 17, 2019
Pear Therapeutics Initiates Feasibility Study to Treat Depressive Symptoms in People with Multiple Sclerosis
May 17, 2019
IDEAYA Receives Authorization to Proceed with Phase 1/2 Tissue-Type Agnostic Basket Trial to Treat Patients with Tumors Harboring GNAQ/11 Mutations and PKC Fusions
May 17, 2019
Audentes Therapeutics Announces Launch of New State-of-the-Art Internal cGMP Plasmid Manufacturing Facility
May 17, 2019
Aprea Therapeutics Receives FDA Fast Track Designation and Orphan Drug Designation for APR-246 for the Treatment of Myelodysplastic Syndromes (MDS)
April 15, 2019
Cidara Selects First Clinical Development Candidate From Its Cloudbreak Influenza (Antiviral) Program
April 11, 2019
NodThera Highlights Significant Progress with Advancement of Lead Development Candidate and Key Additions to Board
April 8, 2019
Audentes Therapeutics Announces Expansion of AAV Technology Platform and Pipeline with New Development Programs for Duchenne Muscular Dystrophy and Mytonic Dystrophy
« Previous Page
1
…
68
69
70
71
72
…
119
Next Page »